These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 25837304)
1. Matrix Metalloproteinase-9 as a Novel Player in Synaptic Plasticity and Schizophrenia. Lepeta K; Kaczmarek L Schizophr Bull; 2015 Sep; 41(5):1003-9. PubMed ID: 25837304 [TBL] [Abstract][Full Text] [Related]
2. MMP-9 in translation: from molecule to brain physiology, pathology, and therapy. Vafadari B; Salamian A; Kaczmarek L J Neurochem; 2016 Oct; 139 Suppl 2():91-114. PubMed ID: 26525923 [TBL] [Abstract][Full Text] [Related]
3. Glutamatergic Dysfunction and Synaptic Ultrastructural Alterations in Schizophrenia and Autism Spectrum Disorder: Evidence from Human and Rodent Studies. Eltokhi A; Santuy A; Merchan-Perez A; Sprengel R Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374598 [TBL] [Abstract][Full Text] [Related]
4. Matrix Metalloproteinase-9 and Synaptic Plasticity in the Central Amygdala in Control of Alcohol-Seeking Behavior. Stefaniuk M; Beroun A; Lebitko T; Markina O; Leski S; Meyza K; Grzywacz A; Samochowiec J; Samochowiec A; Radwanska K; Kaczmarek L Biol Psychiatry; 2017 Jun; 81(11):907-917. PubMed ID: 28190519 [TBL] [Abstract][Full Text] [Related]
5. MMP9: a novel function in synaptic plasticity. Dziembowska M; Wlodarczyk J Int J Biochem Cell Biol; 2012 May; 44(5):709-13. PubMed ID: 22326910 [TBL] [Abstract][Full Text] [Related]
6. miR-132 Regulates Dendritic Spine Structure by Direct Targeting of Matrix Metalloproteinase 9 mRNA. Jasińska M; Miłek J; Cymerman IA; Łęski S; Kaczmarek L; Dziembowska M Mol Neurobiol; 2016 Sep; 53(7):4701-12. PubMed ID: 26319558 [TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase-9 activity increased by two different types of epileptic seizures that do not induce neuronal death: a possible role in homeostatic synaptic plasticity. Takács E; Nyilas R; Szepesi Z; Baracskay P; Karlsen B; Røsvold T; Bjørkum AA; Czurkó A; Kovács Z; Kékesi AK; Juhász G Neurochem Int; 2010; 56(6-7):799-809. PubMed ID: 20303372 [TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory. Nagy V; Bozdagi O; Matynia A; Balcerzyk M; Okulski P; Dzwonek J; Costa RM; Silva AJ; Kaczmarek L; Huntley GW J Neurosci; 2006 Feb; 26(7):1923-34. PubMed ID: 16481424 [TBL] [Abstract][Full Text] [Related]
9. The extracellular matrix glycoprotein tenascin-C and matrix metalloproteinases modify cerebellar structural plasticity by exposure to an enriched environment. Stamenkovic V; Stamenkovic S; Jaworski T; Gawlak M; Jovanovic M; Jakovcevski I; Wilczynski GM; Kaczmarek L; Schachner M; Radenovic L; Andjus PR Brain Struct Funct; 2017 Jan; 222(1):393-415. PubMed ID: 27089885 [TBL] [Abstract][Full Text] [Related]
10. Beta-dystroglycan as a target for MMP-9, in response to enhanced neuronal activity. Michaluk P; Kolodziej L; Mioduszewska B; Wilczynski GM; Dzwonek J; Jaworski J; Gorecki DC; Ottersen OP; Kaczmarek L J Biol Chem; 2007 Jun; 282(22):16036-41. PubMed ID: 17426029 [TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase-9 undergoes expression and activation during dendritic remodeling in adult hippocampus. Szklarczyk A; Lapinska J; Rylski M; McKay RD; Kaczmarek L J Neurosci; 2002 Feb; 22(3):920-30. PubMed ID: 11826121 [TBL] [Abstract][Full Text] [Related]
12. Impact of matrix metalloproteinase-9 overexpression on synaptic excitatory transmission and its plasticity in rat CA3-CA1 hippocampal pathway. Wiera G; Szczot M; Wojtowicz T; Lebida K; Koza P; Mozrzymas JW J Physiol Pharmacol; 2015 Apr; 66(2):309-15. PubMed ID: 25903961 [TBL] [Abstract][Full Text] [Related]
13. MMP-9 Signaling Pathways That Engage Rho GTPases in Brain Plasticity. Figiel I; Kruk PK; Zaręba-Kozioł M; Rybak P; Bijata M; Wlodarczyk J; Dzwonek J Cells; 2021 Jan; 10(1):. PubMed ID: 33467671 [TBL] [Abstract][Full Text] [Related]
14. A normal genetic variation modulates synaptic MMP-9 protein levels and the severity of schizophrenia symptoms. Lepeta K; Purzycka KJ; Pachulska-Wieczorek K; Mitjans M; Begemann M; Vafadari B; Bijata K; Adamiak RW; Ehrenreich H; Dziembowska M; Kaczmarek L EMBO Mol Med; 2017 Aug; 9(8):1100-1116. PubMed ID: 28623238 [TBL] [Abstract][Full Text] [Related]
15. The regulation of dendritic arbor development and plasticity by glutamatergic synaptic input: a review of the synaptotrophic hypothesis. Cline H; Haas K J Physiol; 2008 Mar; 586(6):1509-17. PubMed ID: 18202093 [TBL] [Abstract][Full Text] [Related]
16. Assembly and plasticity of the glutamatergic postsynaptic specialization. McGee AW; Bredt DS Curr Opin Neurobiol; 2003 Feb; 13(1):111-8. PubMed ID: 12593989 [TBL] [Abstract][Full Text] [Related]
17. From c-Fos to MMP-9: In control of synaptic plasticity to produce healthy and diseased mind, a personal view. Kaczmarek L Postepy Biochem; 2018 Oct; 64(2):101-109. PubMed ID: 30656892 [TBL] [Abstract][Full Text] [Related]
18. Alteration of Neuronal Excitability and Short-Term Synaptic Plasticity in the Prefrontal Cortex of a Mouse Model of Mental Illness. Crabtree GW; Sun Z; Kvajo M; Broek JA; Fénelon K; McKellar H; Xiao L; Xu B; Bahn S; O'Donnell JM; Gogos JA J Neurosci; 2017 Apr; 37(15):4158-4180. PubMed ID: 28283561 [TBL] [Abstract][Full Text] [Related]
19. Extracellular Metalloproteinases in the Plasticity of Excitatory and Inhibitory Synapses. Wiera G; Mozrzymas JW Cells; 2021 Aug; 10(8):. PubMed ID: 34440823 [TBL] [Abstract][Full Text] [Related]
20. Synaptic dysfunction in schizophrenia. Yin DM; Chen YJ; Sathyamurthy A; Xiong WC; Mei L Adv Exp Med Biol; 2012; 970():493-516. PubMed ID: 22351070 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]